Medicine and Dentistry
End of Life Care
100%
Cancer
71%
Health Care
67%
Malignant Neoplasm
62%
Breast Cancer
62%
Contralateral
62%
Meta-Analysis
62%
Systematic Review
62%
Pancreas Adenocarcinoma
62%
Down Syndrome
62%
microRNA
62%
Biological Marker
62%
Basal-Cell Carcinoma
62%
Melanoma
62%
Odds Ratio
50%
Symptomatic Treatment
33%
Diseases
29%
Basal Cell Carcinoma Cell
26%
Squamous Cell Carcinoma
26%
Multivariate Analysis
25%
Guilt
20%
CA19-9
17%
Neoplasm
14%
Cancer Incidence
12%
Logistic Regression Analysis
12%
Outpatient
12%
Cancer Treatment
12%
Skin Examination
10%
Health Care Cost
10%
Dermatology
10%
Patient Care
10%
Wilcoxon Signed Ranks Test
8%
Long Term Survival
8%
Secretin
8%
Rank Sum Test
8%
Real-Time Polymerase Chain Reaction
8%
Immunoassay
8%
Sensitivity and Specificity
8%
microRNA 155
8%
Duodenum
8%
Molecular Marker
8%
Assisted Living
7%
Intellectual and Developmental Disabilities
7%
Precancerous Condition
5%
Standardized Incidence Ratio
5%
Secondary Prevention
5%
Independent Reviewer
5%
Subgroup Analysis
5%
Single Isomorphous Replacement
5%
Nursing and Health Professions
Terminal Care
100%
Basal Cell Carcinoma
62%
Dermatologist
62%
Malignant Neoplasm
62%
Down Syndrome
62%
Health Care
62%
Odds Ratio
50%
Nursing Competence
41%
Palliative Therapy
33%
Multivariate Analysis
25%
Practice Guideline
23%
Diseases
20%
Sample Size
20%
Healthcare System
20%
Logistic Regression Analysis
12%
Outpatient
12%
Cancer Incidence
12%
Home Care
12%
General Practitioner
12%
Neoplasm
12%
Intellectual Impairment
8%
Assisted Living Facility
8%
Health Care Need
8%
Intellectual and Developmental Disabilities
8%
Patient Care
7%
Health Care Personnel
7%
Female Patient
7%
Biochemistry, Genetics and Molecular Biology
Cancer Registry
62%
Overall Survival
62%
Pancreatic Juice
62%
MicroRNA
62%
Mortality Rate
62%
CA19-9
13%
Real-Time Polymerase Chain Reaction
6%
Immunoassay
6%
Genetic Marker
6%
MiR-155
6%
Mann-Whitney U Test
6%
Duodenum
6%
Wilcoxon Signed-Rank Test
6%
Electrochemiluminescence
6%
Long Term Survival
6%
Secretin
6%
